Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Tona, F; Serra, R; Di, Ascenzo, L; Osto, E; Scarda, A; Fabris, R; Montisci, R; Famoso, G; Tellatin, S; Foletto, M; Giovagnoni, A; Iliceto, S; Vettor, R.
Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease.
Nutr Metab Cardiovasc Dis. 2014; 24(4):447-53 Doi: 10.1016/j.numecd.2013.09.021
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Osto Elena
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
BACKGROUND AND AIMS: Obesity, systemic inflammation and changes in the heart functions are associated with increased cardiovascular risk. This study aimed to investigate coronary microvascular dysfunction as an early marker of atherosclerosis in obese patients without any evidence of cardiovascular disease. METHODS AND RESULTS: 86 obese subjects (aged 44 ± 12 years, body mass index (BMI) 41 ± 8 kg m(-2)), without evidence of heart disease, and 48 lean controls were studied using transthoracic Doppler echocardiography for detecting coronary flow reserve (CFR). A value of CFR ≤ 2.5 was considered abnormal. We measured interleukin-6 (IL-6), tumour necrosis factor-α (TNF-α) and adiponectin in all patients. Patients with abnormal CFR underwent coronary multislice computed tomography (MSCT) in order to exclude an epicardial stenosis. CFR in obese subjects was lower than in lean subjects (3.2 ± 0.8 vs. 3.7 ± 0.7, p = 0.02) and was abnormal in 27 (31%) obese patients and in one (2%) control (p < 0.0001). All subjects with abnormal CFR showed no coronary stenosis at MSCT. At multivariable analysis, IL-6 and TNF-α were the only determinants of CFR (p < 0.02 and p < 0.02, respectively). At multivariable logistic regression analysis, IL-6 and TNF-α were the only determinants of CFR ≤ 2.5 (p < 0.03 and p < 0.03, respectively). CONCLUSIONS: CFR is often reduced in obese subjects without clinical evidence of heart disease, suggesting a coronary microvascular impairment. This microvascular dysfunction seems to be related to a chronic inflammation mediated by adipocytokines. Our findings may explain the increased cardiovascular risk in obesity, independently of BMI.
Find related publications in this database (using NLM MeSH Indexing)
Adiponectin - blood
Adult - administration & dosage
Biomarkers - blood
Body Mass Index - administration & dosage
Case-Control Studies - administration & dosage
Chi-Square Distribution - administration & dosage
Coronary Angiography - methods
Coronary Artery Disease - diagnosis, etiology, physiopathology
Coronary Vessels - diagnostic imaging, physiopathology
Cross-Sectional Studies - administration & dosage
Echocardiography, Doppler - administration & dosage
Female - administration & dosage
Fractional Flow Reserve, Myocardial - administration & dosage
Humans - administration & dosage
Inflammation - blood, complications, diagnosis
Inflammation Mediators - blood
Interleukin-6 - blood
Logistic Models - administration & dosage
Male - administration & dosage
Microcirculation - administration & dosage
Microvessels - diagnostic imaging, physiopathology
Middle Aged - administration & dosage
Multidetector Computed Tomography - administration & dosage
Multivariate Analysis - administration & dosage
Obesity - blood, complications, diagnosis
Predictive Value of Tests - administration & dosage
Risk Factors - administration & dosage
Severity of Illness Index - administration & dosage
Tumor Necrosis Factor-alpha - blood

Find related publications in this database (Keywords)
Obesity
Microvascular dysfunction
Coronary flow reserve
Inflammation
Prevention
© Med Uni GrazImprint